Misonix Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2021 to a ratio of 6.41, above the company average. This is a clear sign of healthy business climate in the Laboratory Analytical Instruments industry and improving liquidity at their respective customers, during the fourth quarter 2021. Average receivable collection period, for the Misonix Inc in Jun 30 2021 quarter, has decreased to 57 days, compared to 62 days, in the Mar 31 2021 quarter.

If we take a look into Healthcare sector 305 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2021 from 2229 to 2319.

What is Receivable Turnover Ratio?
What is Misonix Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MSON Receivables Turnover Ratio	(Jun 30 2021) IV. Quarter	(Mar 31 2021) III. Quarter	(Dec 31 2020) II. Quarter	(Sep 30 2020) I. Quarter	(Jun 30 2020) IV. Quarter
Y / Y Receivable Change	2.58 %	-18.15 %	-14.38 %	-7.86 %	106.41 %
Y / Y Revenue Change	43.55 %	2.48 %	-7.43 %	59.12 %	40.59 %
Receivable Turnover Ratio (TTM)	6.41	5.93	5.57	5.48	4.86
MSON's Total Ranking	# 2319	# 2229	# 2234	# 2229	# 1957
Accounts Receivable average collection period days	57	62	66	67	75
Seq. Receivable Change	-5.69 %	8.64 %	-5.54 %	5.99 %	-24.75 %
Seq. Revenue Change	7.29 %	0.5 %	2.94 %	29.33 %	-23.4 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 16
Healthcare Sector	# 306
Overall Market	# 2319

Receivable Turnover Ratio Statistics
High	Average	Low
1.38	0.86	0.33
(Dec 31 2018)		(Jun 30 2020)

MSON Company Profile • Back to MSON Efficiency Comparisons • Compare MSON Receivables Turnover Ratio to its Competitors

Financial Statements
Misonix Inc 's Accounts Receivable	$ 11 Millions	Visit MSON's Balance sheet
Misonix Inc 's Sales TTM	$ 74 Millions	Visit MSON's Income Statement
Sources of MSON's Revenues		Visit MSON's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MSON's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MSON's Growth Rates	MSON's Roa	MSON's Inventory Turnover Ratio	MSON's Dividend Comparisons
MSON's Profitability Ratios	MSON's Roi	MSON's Asset Turnover Ratio	MSON's Dividend Growth
MSON's Valuation Ratios	MSON's Roe	MSON's Financial Strength Ratios	MSON's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2021	Receivable at quarter ending Jun 30 2021
Dariohealth Corp	17.69	$ 11.360 Millions	$ 0.642 Millions
Cormedix Inc	17.43	$ 0.245 Millions	$ 0.014 Millions
Rafael Holdings Inc	17.34	$ 3.971 Millions	$ 0.229 Millions
Neurometrix Inc	17.27	$ 8.215 Millions	$ 0.476 Millions
Inhibrx Biosciences Inc	17.08	$ 10.520 Millions	$ 0.616 Millions
Electrocore Inc	16.68	$ 4.482 Millions	$ 0.269 Millions
Cytomx Therapeutics Inc	16.51	$ 66.420 Millions	$ 4.022 Millions
Scorpius Holdings inc	16.47	$ 2.451 Millions	$ 0.149 Millions
Mannkind Corporation	16.35	$ 74.511 Millions	$ 4.558 Millions
Protalix Biotherapeutics inc	15.91	$ 48.032 Millions	$ 3.019 Millions
Merus N v	15.82	$ 38.315 Millions	$ 2.422 Millions
Catheter Precision Inc	15.46	$ 4.254 Millions	$ 0.275 Millions
Concert Pharmaceuticals Inc	15.41	$ 33.530 Millions	$ 2.176 Millions
Histogen Inc	15.38	$ 2.387 Millions	$ 0.155 Millions
Nutriband Inc	15.22	$ 1.387 Millions	$ 0.091 Millions
Longeveron Inc	15.05	$ 0.489 Millions	$ 0.033 Millions
Travere Therapeutics Inc	14.93	$ 201.593 Millions	$ 13.507 Millions
Xencor Inc	14.79	$ 178.632 Millions	$ 12.082 Millions
Chimerix Inc	14.74	$ 4.555 Millions	$ 0.309 Millions
Chemocentryx Inc.	14.69	$ 38.860 Millions	$ 2.646 Millions
Ultragenyx Pharmaceutical Inc	14.29	$ 359.382 Millions	$ 25.152 Millions
Myomo Inc	14.26	$ 11.157 Millions	$ 0.783 Millions
Dmk Pharmaceuticals Corporation	14.20	$ 16.058 Millions	$ 1.131 Millions
Patterson Companies Inc	14.19	$ 6,281.105 Millions	$ 442.648 Millions
Fulcrum Therapeutics Inc	14.14	$ 15.243 Millions	$ 1.078 Millions
Ppd Inc	14.10	$ 5,551.946 Millions	$ 393.712 Millions
Corcept Therapeutics Inc	14.01	$ 343.087 Millions	$ 24.494 Millions
Cytokinetics Incorporated	13.93	$ 57.801 Millions	$ 4.150 Millions
Lexicon Pharmaceuticals Inc	13.92	$ 7.094 Millions	$ 0.510 Millions
Timber Pharmaceuticals Inc	13.92	$ 0.883 Millions	$ 0.063 Millions

Date modified: 2026-06-22T16:30:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.